New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.

Sivaprasad S, Cheung CMG, Gliem M, Wykoff CC, Zippel N, Ishida S, Dong Nguyen Q

DOI: 10.1038/s41433-025-03835-w
Published: 2025 Dec
Container: Eye (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41433-025-03835-w,
  title = {New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.},
  author = {Sivaprasad S and Cheung CMG and Gliem M and Wykoff CC and Zippel N and Ishida S and Dong Nguyen Q},
  year = {2025},
  journal = {Eye (London, England)},
  doi = {10.1038/s41433-025-03835-w},
  url = {https://doi.org/10.1038/s41433-025-03835-w}
}

RIS

TY  - JOUR
TI  - New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.
AU  - Sivaprasad S
AU  - Cheung CMG
AU  - Gliem M
AU  - Wykoff CC
AU  - Zippel N
AU  - Ishida S
AU  - Dong Nguyen Q
PY  - 2025
JO  - Eye (London, England)
DO  - 10.1038/s41433-025-03835-w
UR  - https://doi.org/10.1038/s41433-025-03835-w
ER  -

APA

S, S., CMG, C., M, G., CC, W., N, Z., S, I., & Q, D. N. (2025). New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway.. Eye (London, England). https://doi.org/10.1038/s41433-025-03835-w

Source records

pubmed · retrieved 2026-09-26T05:49:16.108Z